{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:21:07Z","timestamp":1784323267400,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cvsm.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T01:15:20Z","timestamp":1690334120000},"page":"1277-1292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predicting Development of Hypertrophic Cardiomyopathy and Disease Outcomes in Cats"],"prefix":"10.1016","volume":"53","author":[{"given":"Jose","family":"Novo Matos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie Rose","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2023.05.012_bib1","first-page":"39","article-title":"Hypertrophic cardiomyopathy. Clinical and pathologic correlates","volume":"5","author":"Fox","year":"2003","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cvsm.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jvim.15745","article-title":"ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats","volume":"34","author":"Luis Fuentes","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2460\/javma.234.11.1398","article-title":"Prevalence of cardiomyopathy in apparently healthy cats","volume":"234","author":"Paige","year":"2009","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2023.05.012_bib5","first-page":"S244","article-title":"Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)","volume":"17","author":"Payne","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"issue":"5","key":"10.1016\/j.cvsm.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.echo.2011.03.006","volume":"24","author":"Nagueh","year":"2011","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cvsm.2023.05.012_bib7","first-page":"169","article-title":"Contemporary diagnosis and management of hypertrophic cardiomyopathy: The role of echocardiography and multimodality imaging","volume":"9","author":"Kitai","year":"2022","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.cvsm.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","article-title":"Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy. Correlation with histopathology and prevalence of ventricular aachycardia","volume":"54","author":"Kwon","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9149(01)01640-X","article-title":"Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy","volume":"88","author":"Varnava","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2559.2004.01835.x","article-title":"The pathology of hypertrophic cardiomyopathy","volume":"44","author":"Hughes","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.cvsm.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10554-017-1214-z","article-title":"Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance","volume":"34","author":"Maragiannis","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cvsm.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2010.03.020","article-title":"Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"106","author":"Olivotto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.cvsm.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jvc.2023.02.002","article-title":"Thin and hypokinetic myocardial segments in cats with cardiomyopathy","volume":"46","author":"Novo Matos","year":"2023","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib15","first-page":"S102","article-title":"Echocardiographic evaluation of left ventricular diastolic function in cats: Hemodynamic determinants and pattern recognition","volume":"17","author":"Schober","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/jvim.15777","article-title":"Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy","volume":"34","author":"Rohrbaugh","year":"2020","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib18","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2006.02.048","article-title":"Left atrial size. Physiologic determinants and clinical applications","volume":"47","author":"Abhayaratna","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jvim.15122","article-title":"International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL Study","volume":"32","author":"Fox","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib20","first-page":"1","article-title":"Echocardiographic assessment of left ventricular geometry and the mitral valve apparatus in cats with hypertrophic cardiomyopathy","volume":"12","author":"Schober","year":"2010","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2460\/javma.1992.201.04.613","article-title":"Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989)","volume":"201","author":"Atkins","year":"1992","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2460\/javma.2002.220.202","article-title":"Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999)","volume":"220","author":"Rush","year":"2002","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1098-612X(02)00133-X","article-title":"Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994-2001)","volume":"5","author":"Ferasin","year":"2003","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1748-5827.2010.00989.x","article-title":"Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005)","volume":"51","author":"Payne","year":"2010","journal-title":"J\u00a0Small Anim Pract"},{"key":"10.1016\/j.cvsm.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1939-1676.2012.00906.x","article-title":"Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in 5 breeds of cats: a retrospective analysis of 344 cases (2001-2011)","volume":"26","author":"Trehiou-Sechi","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1098612X20938651","article-title":"Risk indictors in cats with preclinical hypertrophic cardiomyopathy: a prospective cohort study","volume":"23","author":"Ironside","year":"2021","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2023.05.012_bib27","first-page":"S318","article-title":"Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy","volume":"17","author":"Payne","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jvim.16576","article-title":"Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: the CatScan II study","volume":"36","author":"Novo Matos","year":"2022","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib29","first-page":"154","article-title":"Prognostic value of mitral annular systolic plane excursion and tricuspid annular plane systolic excursion in cats with hypertrophic cardiomyopathy","volume":"20","author":"Spalla","year":"2018","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamacardio.2016.5670","article-title":"The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet study","volume":"2","author":"Ho","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.cvsm.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/eurheartj\/ehq111","article-title":"Editorial: Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy","volume":"31","author":"Maron","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cvsm.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","article-title":"Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy","volume":"105","author":"Ho","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cvsm.2023.05.012_bib34","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/heartjnl-2016-310015","article-title":"Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers","volume":"102","author":"Ho","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cvsm.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12968-017-0420-0","article-title":"Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"19","author":"Farhad","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.cvsm.2023.05.012_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCGENETICS.109.862128","article-title":"Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy","volume":"2","author":"Ho","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cvsm.2023.05.012_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0002-9149(02)02434-7","article-title":"Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy","volume":"90","author":"Cardim","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.CIR.0000084500.72232.8D","article-title":"Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease","volume":"108","author":"Nagueh","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cvsm.2023.05.012_bib39","doi-asserted-by":"crossref","first-page":"27714","DOI":"10.1038\/srep27714","article-title":"The embryological basis of subclinical hypertrophic cardiomyopathy","volume":"6","author":"Captur","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cvsm.2023.05.012_bib40","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.amjcard.2011.07.019","article-title":"Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy","volume":"108","author":"Lakdawala","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2011.07.095","article-title":"Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy","volume":"152","author":"Gray","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.118.037264","article-title":"Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy","volume":"139","author":"Maurizi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cvsm.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCIMAGING.114.002411","article-title":"Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy","volume":"7","author":"Captur","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cvsm.2023.05.012_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cvsm.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ehjci\/jes005","article-title":"Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers","volume":"13","author":"Brouwer","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cvsm.2023.05.012_bib46","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib47","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cvsm.2023.05.012_bib49","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/hmg\/ddi386","article-title":"A\u00a0cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy","volume":"14","author":"Meurs","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cvsm.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygeno.2007.04.007","article-title":"A\u00a0substitution mutation in the myosin binding protein C gene in Ragdoll hypertrophic cardiomyopathy","volume":"90","author":"Meurs","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.cvsm.2023.05.012_bib51","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/s41431-019-0431-4","article-title":"A\u00a0feline orthologue of the human MYH7 c.5647G>A (p.(Glu1883Lys)) variant causes hypertrophic cardiomyopathy in a Domestic Shorthair cat","volume":"27","author":"Schipper","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.cvsm.2023.05.012_bib52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-021-01740-5","article-title":"A\u00a0deleterious mutation in the ALMS1 gene in a naturally occurring model of hypertrophic cardiomyopathy in the Sphynx cat","volume":"16","author":"Meurs","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cvsm.2023.05.012_bib53","first-page":"62","article-title":"Anterior mitral valve leaflet length in cats with hypertrophic cardiomyopathy","volume":"37","author":"Seo","year":"2021","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1939-1676.2008.0218.x","article-title":"Prospective echocardiography and tissue Doppler imaging screening of a population of maine coon cats tested for the A31P mutation in the myosin-binding protein c gene: A specific analysis of the heterozygous status","volume":"23","author":"Sampedrano","year":"2009","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1740-8261.2006.00143.x","article-title":"Two-dimensional color tissue doppler imaging detects myocardial dysfunction before occurrence of hypertrophy in a young maine coon cat","volume":"47","author":"Chetboul","year":"2006","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.cvsm.2023.05.012_bib56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1939-1676.2007.tb02954.x","article-title":"Tissue Doppler imaging in maine coon cats with a mutation of myosin binding protein C with or without hypertrophy","volume":"21","author":"MacDonald","year":"2007","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib57","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/jvim.16067","article-title":"Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy","volume":"35","author":"Fries","year":"2021","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib58","first-page":"S258","article-title":"The influence of clinical and genetic factors on left ventricular wall thickness in Ragdoll cats","volume":"17","author":"Borgeat","year":"2015","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tvjl.2014.11.018","article-title":"Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy","volume":"203","author":"Khor","year":"2015","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2023.05.012_bib60","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ahj.2011.05.018","article-title":"Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy","volume":"162","author":"De","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.cvsm.2023.05.012_bib61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"Heart disease: A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cvsm.2023.05.012_bib62","doi-asserted-by":"crossref","first-page":"e0168407","DOI":"10.1371\/journal.pone.0168407","article-title":"A\u00a0small molecule inhibitor of sarcomere contractility acutely relieves left ventricular outflow tract obstruction in feline hypertrophic cardiomyopathy","volume":"11","author":"Stern","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cvsm.2023.05.012_bib63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cvsm.2023.05.012_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jacc.2022.10.020","article-title":"Phase 2 Study of aficamten in patients with obstructive hypertrophic cardiomyopathy","volume":"81","author":"Maron","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib65","first-page":"32","article-title":"Effects of aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy","volume":"13","author":"Sharpe","year":"2023","journal-title":"Sci Reports"},{"key":"10.1016\/j.cvsm.2023.05.012_bib66","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.CIR.85.5.1651","article-title":"Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy","volume":"85","author":"Klues","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.cvsm.2023.05.012_bib67","first-page":"23","article-title":"Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy","volume":"30","author":"Ferasin","year":"2020","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib68","article-title":"Early detection of myocardial dysfunction using two-dimensional speckle tracking echocardiography in a young cat with hypertrophic cardiomyopathy","volume":"4","author":"Suzuki","year":"2018","journal-title":"J\u00a0Feline Med Surg Open Rep"},{"key":"10.1016\/j.cvsm.2023.05.012_bib69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1939-1676.1993.tb03184.x","article-title":"Heterogeneity of hypertrophy in feline hypertrophic heart disease","volume":"7","author":"Peterson","year":"1993","journal-title":"J\u00a0Vet Intern Med"},{"issue":"9","key":"10.1016\/j.cvsm.2023.05.012_bib70","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.92.9.2645","article-title":"Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: an animal model of human disease","volume":"92","author":"Fox","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cvsm.2023.05.012_bib71","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/jvim.12215","article-title":"Prognostic indicators in cats with hypertrophic cardiomyopathy","volume":"27","author":"Payne","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1098612X15588797","article-title":"Survival in cats with primary and secondary cardiomyopathies","volume":"18","author":"Spalla","year":"2016","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2023.05.012_bib73","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jvim.12459","article-title":"Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy","volume":"28","author":"Borgeat","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib74","first-page":"73","article-title":"Association of the myosin binding protein C3 mutation (MYBPC3 R820W) with cardiac death in a survey of 236 Ragdoll cats","volume":"16","author":"Borgeat","year":"2014","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tvjl.2018.11.005","article-title":"Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy","volume":"243","author":"Bartoszuk","year":"2019","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2023.05.012_bib76","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2460\/javma.2004.225.256","article-title":"Atrial fibrillation in cats: 50 Cases (1979-2002)","volume":"225","author":"C\u00f4t\u00e9","year":"2004","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2023.05.012_bib77","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tvjl.2015.08.017","article-title":"Sleeping and resting respiratory rates in dogs and cats with medically-controlled left-sided congestive heart failure","volume":"207","author":"Porciello","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2023.05.012_bib78","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/jvim.14697","article-title":"Mitral annular plane systolic excursion and tricuspid annular plane systolic excursion in cats with hypertrophic cardiomyopathy","volume":"31","author":"Spalla","year":"2017","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib79","first-page":"93","article-title":"Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy","volume":"15","author":"Schober","year":"2013","journal-title":"J\u00a0Vet Cardiol"},{"key":"10.1016\/j.cvsm.2023.05.012_bib80","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/jvim.12407","article-title":"Cardiac troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy","volume":"28","author":"Langhorn","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jvim.12249","article-title":"Arterial thromboembolism in 250 Cats in general practice: 2004-2012","volume":"28","author":"Borgeat","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2023.05.012_bib82","first-page":"S306","article-title":"Secondary Prevention of Cardiogenic Arterial Thromboembolism in the Cat: The Double-Blind, Randomized, Positive-Controlled Feline Arterial Thromboembolism; Clopidogrel vs. Aspirin Trial (FAT CAT)","author":"Hogan","year":"2015","journal-title":"J\u00a0Vet Cardiol"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561623000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561623000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:50:03Z","timestamp":1759283403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561623000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0195561623000852"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.012","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Development of Hypertrophic Cardiomyopathy and Disease Outcomes in Cats","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}